|
|
||||||||

*
The Arthritis Center of Excellence, Toronto Hospital Research Institute, Toronto Hospital-Western Division, and
Departments of Medicine and Immunology, University of Toronto, Toronto, Ontario, Canada
Recent crystallographic studies suggest that TCR interact with
peptide/class I MHC complexes in a single preferred orientation.
Although similar studies have not been performed for class
II-restricted TCR, it has been proposed that T cell recognition of
peptide/class II complexes has similar orientational restrictions. This
study represents a functional approach to systematic analysis of this
question. Twenty-one mutant Aßd molecules
were produced by alanine scanning mutagenesis and assessed for their
ability to present species variants of insulin to a panel of beef
insulin-specific T cell hybridomas with limited TCR
- and/or
ß-chain sequence differences. We demonstrate that all beef
insulin-specific TCR have the same orientation on the
insulin/Ad complex, such that the
-chain interacts with
the carboxyl-terminal region of the Aßd
-helix, and the ß-chain complementarity-determining region 3
interacts with the carboxyl-terminal portion of the peptide, consistent
with that observed for crystallized TCR-peptide/class I complexes.
Despite this structural constraint, even TCR that share structural
similarity show remarkable heterogeneity in their responses to the
panel of MHC mutants. This variability appears to result from
conformational changes induced by binding of the TCR to the complex and
the exquisite sensitivity of the threshold for T cell
activation.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |